Search

everythinglearnresearchcommunity

for

Search:↓

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

A new compound effectively inhibits human 5α-reductase 1.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Clq deficiency is linked to systemic lupus erythematosus symptoms.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Some birth control pills increase blood clot risk; use them for specific conditions only.

Intralesional vitamin D3 is an effective and safe treatment for patchy alopecia areata with fewer side effects.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Cromolyn sodium oleate gel is more effective and safer for treating atopic dermatitis than dexamethasone.

A new compound shows promise as a topical treatment for hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

The drug combination significantly reduced epileptic drop attacks in patients.

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.